Penny Stocks
ESLA: Two Infusions, One Patient—and a Bigger Cancer-Therapy Question
Estrella’s recent EB103 update provides an early clinical milestone to examine. A small, short follow-up cannot establish broad safety or treatment benefit.
Read the story